Lv1
50 积分 2024-11-17 加入
Intestinal barrier disorders and metabolic endotoxemia in obesity: Current knowledge
3小时前
求助中
Comparison of Rate Versus Rhythm Control for Atrial Fibrillation in Patients With Left Ventricular Dysfunction (from the AFFIRM Study)
7个月前
已完结
A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)
7个月前
已完结
15th ISoP Annual Meeting “Cubism in Pharmacovigilance” Prague, Czech Republic 27-30 October, 2015
8个月前
已完结
Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
8个月前
已完结
EFFECT OF REMOGLIFLOZIN ON BIOMARKERS COMPARED TO EMPAGLIFLOZIN INPATIENTS OF TYPE 2 DIABETES MELLITUS WITH CHRONIC HEART FAILURE (REMIT HF)
10个月前
已完结
Impacto pronóstico de metformina en pacientes con diabetes mellitus tipo 2 e insuficiencia cardiaca aguda. Análisis combinado de los registros EAHFE y RICA
11个月前
已完结
Open-label, Randomized, Multi-Centre study to evaluate safety and efficacy of Remogliflozin in patients with Type 2 diabetes mellitus with acute decompensated heart failure (HF with reduced ejection fraction, HFrEF). (Remo Safe-AHF Study)
11个月前
已关闭
皖公网安备34019202002308
